A Randomized, Double‐Blind, Single‐Dose, Crossover Study to Demonstrate the Bioequivalence of 2 Formulations of Albiglutide in Healthy Adult Participants

Albiglutide, developed for treatment of type 2 diabetes mellitus, is provided in a dual‐chamber cartridge (DCC) single‐dose pen‐injector containing lyophilized drug that must be reconstituted with diluent prior to use. A liquid formulation of albiglutide has been developed that does not require mixi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical pharmacology in drug development 2019-04, Vol.8 (3), p.361-370
Hauptverfasser:	Shaddinger, Bonnie C., Vlasakakis, Georgios, Soffer, Joseph, Thorpe, Karl M., Hatch, Daniel, Nino, Antonio J.
Format:	Artikel
Sprache:	eng
Schlagworte:	albiglutide Bioequivalence Confidence intervals Diabetes Double-blind studies Drug dosages GLP‐1 receptor agonist pharmacokinetics Pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!